Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02429 |
| Species: | Mus musculus |
| Position : | chr17:44464986-44466986 |
| Year: | 2014 |
| Title: | Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 24692107 |
| Cell Source: | Osteoblast-Specific Cell |
| Experiment Type: | Enhancer activity assay; TF-binding/chromatin assay; In vivo functional validation |
| Low Throughput Method: | Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP; EMSA/gel-shift assay; Transgenic/LacZ assay |
| Target gene : | Runx2 |
| TF name : | Dlx5 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Dlx5 | Validated transcriptional targets of deltaNp63 isoforms | pid | 47 |
| Dlx5 | Hs_MECP2_and_Associated_Rett_Syndrome_WP3584_91190 | wikipathways | 12 |
| Dlx5 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |